Dov Goldstein

Dov Goldstein, currently serving as the Chief Financial Officer at BioAge Labs, has an extensive background in finance and healthcare. With previous roles as Director at NeuBase Therapeutics, Inc. and Indapta Therapeutics, Goldstein's career spans multiple companies within the biotechnology and pharmaceutical industries. With a solid educational foundation from Yale School of Medicine, Columbia Business School, and Stanford University, Goldstein brings a wealth of knowledge and experience to their current role.